CLC Number:
- R473.77
| [1] Liyue H, Chiang P C, Sung S C, et al.Dry Eye-Related Visual Blurring and Irritative Symptoms and Their Association with Depression and Anxiety in Eye Clinic Patients[J]. Curr Eye Res, 2016,41(5):590-599.DOI:10.3109/02713683.2015.1056804. [2] Yamada M, Mizuno Y, Shigeyasu C.Impact of Dry Eye on Work Productivity[J]. Clinicoecon Outcomes Res, 2012, 4:307-312. DOI:10.2147/CEOR.S36352. [3] Tilborg M M, Murphy P J, Evans K S.Impact of Dry Eye Symptoms and Daily Activities in a Modern Office[J]. Optom Vis Sci, 2017, 94(6):688.DOI:10.1097/OPX.0000000000001086. [4] Sullivan B D, Crews L A, Messmer E M, et al.Correlations Between Commonly Used Objective Signs and Symptoms for the Diagnosis of Dry Eye Disease: Clinical Implications[J]. Acta Ophthalmol, 2014, 92(2):161-166.DOI:10.1111/aos.12012. [5] Eloy V, María Teresa R A, Dolores A, et al. Prevalence of Asymptomatic and Symptomatic Meibomian Gland Dysfunction in the General Population of Spain[J]. Invest Ophthalmol Vis Sci, 2012, 53(6):2601-2606.DOI:10.1167/iovs.11-9228. [6] Schiffman R M, Christianson M D, Jacobsen G, et al.Reliability and Validity of the Ocular Surface Disease Index[J]. Arch Ophthalmol, 2000, 118(5):615-621. DOI:10.1001/archopht.118.5.615. [7] 林晨,杨敏敏,郑虔.眼表疾病指数量表中文版的研制和性能评价[J]. 眼科新进展, 2013,33(1):38-40.DOI:10.13389/j.cnki.rao.2013.01.011. [8] 马子伟,韩伟,杨卫华. 应用Keratograph眼表综合分析仪分析老年人干眼症状与体征的相关性[J]. 中国老年学杂志, 2019, 39(9):2159-2163. DOI:CNKI:SUN:ZLXZ.0.2019-09-040. [9] Finis D, Pischel N, Schrader S, et al.Evaluation of Lipid Layer Thickness Measurement of the Tear Film as a Diagnostic Tool for Meibomian Gland Dysfunction[J]. Cornea, 2013, 32(12):1549-1553.DOI:10.1097/ICO.0b013e3182a7f3e1. [10] Yazdani M, Chen X, Tashbayev B, et al.Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients[J].Curr Eye Res, 2019,4(16):972.DOI:10.1080/02713683.2019.1604972. [11] Messina M, Dua H S. Early Results on the Use of Chitosan- N -acetylcysteine (Lacrimera ) in the Management of Dry Eye Disease of Varied Etiology[J]. Int Ophthalmol, 2019,39(3):639-696.DOI10.1007/s10792-018-0843-0. [12] Chen X, Yuan R, Sun M, et al.Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye after Phacoemulsification[J]. BMC Ophthalmology, 2019,19(1):13.DOI:10.1186/s12886-018-1023-8. [13] Abetz L, Rajagopalan K, Mertzanis P, et al.Development and Validation of the Impact of Dry Eye on Everyday Life (IDEEL) Questionnaire, a Patient-Reported Outcomes (PRO) Measure for the Assessment of the Burden of Dry Eye on Patients[J]. Health Qual Life Outcomes, 2011, 9(1):111.DOI:10.1186/1477-7525-9-111. [14] Rajagopalan K, Abetz L, Mertzanis P, et al.Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-related Quality of Life Measures in a Sample of Patients with Dry Eye[J].Value in Health, 2005,8(2):168-174.DOI:10.111/j.1524-4733.2005.03074.x. [15] Acaster S, Verboven Y, Begley C, et al.PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity Groups[J]. Value in Health, 2011,14(7):507-508.DOI:10.1016/j.jval.2011.08.1497. [16] Fairchild C J, Chalmers R L, Begley C G.Clinically Important Difference in Dry Eye: Change in IDEEL-symptom Bother[J]. Optom Vis Sci, 2008,85(8):699-707.DOI:10.1097/OPX.0b013e3181824e0d. [17] Bang Z, Liu X J, Sun Y Q F, et al. Development and Validation of the Chinese Version of Dry Eye Related Quality of Life Scale[J]. Health Qual Life Outcomes, 2017,15(1):145.DOI:10.1186/s12955-017-0718-5. [18] Yuri S, Masahiko Y, Norihiko Y, et al.Development and Validation of the Dry Eye-related Quality-of-life Score Questionnaire[J]. Jama Ophthalmol, 2013,131(10):1331-1338.DOI:10.1001/jamaophthalmol.2013.4503. [19] Yazdani-Ibn-Taz M K, Han M M, Jonuscheit S, et al. Patient-reported Severity of Dry Eye and Quality of Life in Diabetes[J]. Clin ophthalmol, 2019,13:217-224.DOI:10.2147/OPTH.S184173. [20] Kobashi H, Kamiya K, Sambe T, et al.Factors Influencing Subjective Symptoms in Dry Eye Disease[J]. Int J Ophthalmol, 2018, 11(12):1926-1931. DOI:10.18240/ijo.2018.12.08. [21] Ishikawa S, Takeuchi M, Kato N.The Combination of Strip Meniscometry and Dry Eye-related Quality-of-life Score Is Useful for Dry Eye Screening During Health Checkup Cross-Sectional Study[J]. JCR, 2018,97(43):e12969.DOI:10.1097/MD.0000000000012969. [22] Sano K, Kawashima M, Takechi S, et al.Exercise Program Improved Subjective Dry Eye Symptoms for Office Workers[J].Clin Ophthalmol,2018,12:307-311.DOI:10.2147/OPTH.S149986. [23] Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, et al.Creating a Specific Diagnostic and Quality-of-life Questionnaire for Patients with Ocular Surface Disease[J]. J Fr Ophtalmol,2003,26(2):119-130.DOI:10.1167/iovs.02-0361. [24] Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, et al.Severe Impairment of Health-related Quality of Life in Patients Suffering from Ocular Surface Diseases[J]. J Fr Ophtalmol, 2008,31(4):369-378.DOI:10.1016/S0181-5512(08)71431-1. [25] Joseph G, Kyle H, Sue T R, et al.Instrument Development of the UNC Dry Eye Management Scale[J]. Cornea, 2014,33(11):1186-1192.DOI:10.1097/ICO.0000000000000243. [26] Bitar M S, Olson D J, Li M, et al.The Correlation Between Dry Eyes, Anxiety and Depression: The Sicca, Anxiety and Depression Study[J]. Cornea, 2019,38(6):684-689.DOI:10.1097/ICO.0000000000001932. [27] Hwang C J, Ellis R, Davis R M, et al.Determination of the Minimal Clinically Important Difference of the University of North Carolina Dry Eye Management Scale[J]. Cornea, 2017, 36(9):1054-1060. DOI:10.1097/ICO.0000000000001287. [28] Mangione C, Lee P, Pitts J, et al.Psychometric Properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ)[J]. Arch Ophthalmol, 1998, 11(116):1496-1504.DOI:10.1001/archopht.116.11.1496. [29] Mangione C M, Lee P P, Gutierrez P R, et al.Development of the 25-item National Eye Institute Visual Function Questionnaire[J]. Arch Ophthalmol, 2001,119(7):1050.DOI: 10.1097/00132578-200201000-00028. [30] Toprak A, Eser E, Guler C, et al.Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25)[J].Ophthalmic Epidemiol,2005,12(4):11.DOI:10.1080/09286580590967763. [31] Suzukamo Y, Oshika T, Yuzawa M, et al.Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25),Japanese version[J]. Health Qual Life Outcomes,2005,3(1):65.DOI:10.1186/1477-7525-3-65. [32] Labiris G, Katsanos A, Fanariotis M, et al.Psychometric Properties of the Greek Version of the NEI-VFQ 25[J]. BMC Ophthalmol, 2008,8(1):4.DOI:10.1186/1471-2415-8-4. [33] Nordmann J, Sullivan K, Viala M, et al.Psychometric Validation of the NEI-VFQ 25 French Version in a Population of Patients Treated for Ocular Hypertension and Glaucoma[J]. Value in Health, 2003,6(6):641.DOI:10.1016/S1098-3015(10)61642-7. [34] Kovac B, Vukosavljevic M, Kovac J D, et al.Validation and Cross-cultural Adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients[J]. Health Qual Life Outcomes, 2015,13(1):142.DOI:10.1186/s12955-015-0330-5. [35] Wang C, Chan C L, Jin H.Psychometric Properties of the Chinese Version of the 25-item National Eye Institute Visual Function Questionnaire[J]. Optom Vis Sci, 2008,85(11):1091-1099.DOI:10.1097/OPX.0b013e31818b9f23. [36] Vitale S, Goodman L A, Reed G F, et al.Comparison of the NEI-VFQ and OSDI Questionnaires in Patients With Sjögren's Syndrome-Related Dry Eye[J]. Health Qual Life Outcomes, 2004,2(1):44.DOI:10.1186/1477-7525-2-44. [37] 刘小虎,邹浩东,李娟,等. 中药熏蒸联合泪道栓子对重度干眼患者视觉相关生存质量的影响[J]. 中国中医眼科杂志, 2019, 29(3):202-205.DOI:10.13444/j.cnki.zgzyykzz.2019.03.008. [38] Ji M A, Lee S H, Rim T H T, et al. Prevalence of and Risk Factors Associated with Dry Eye: The Korea National Health and Nutrition Examination Survey 2010-2011[J]. Am J Ophthalmol, 2014,92(4):e317-e325.DOI:10.1111/aos.12355. [39] La P W S, de Souza R B, Gomes J Á, et al. The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease[J]. Am J Ophthalmol, 2016,163:167-173.DOI:10.1016/j.ajo.2015.11.034. |
|